These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 9699649)
1. Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor. Long L; Navab R; Brodt P Cancer Res; 1998 Aug; 58(15):3243-7. PubMed ID: 9699649 [TBL] [Abstract][Full Text] [Related]
2. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer. Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198 [TBL] [Abstract][Full Text] [Related]
4. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Zhang D; Brodt P Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin. Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905 [TBL] [Abstract][Full Text] [Related]
6. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629 [TBL] [Abstract][Full Text] [Related]
7. Enhanced invasion and liver colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Long L; Rubin R; Brodt P Exp Cell Res; 1998 Jan; 238(1):116-21. PubMed ID: 9457063 [TBL] [Abstract][Full Text] [Related]
8. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1. Huang CS; Fan YE; Lin CY; Hu ML J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831 [TBL] [Abstract][Full Text] [Related]
9. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Long L; Rubin R; Baserga R; Brodt P Cancer Res; 1995 Mar; 55(5):1006-9. PubMed ID: 7866982 [TBL] [Abstract][Full Text] [Related]
10. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Zhang D; Samani AA; Brodt P Horm Metab Res; 2003; 35(11-12):802-8. PubMed ID: 14710361 [TBL] [Abstract][Full Text] [Related]
11. Regulation of gelatinase-A (MMP-2) production by ovine intervertebral disc nucleus pulposus cells grown in alginate bead culture by Transforming Growth Factor-beta(1)and insulin like growth factor-I. Pattison ST; Melrose J; Ghosh P; Taylor TK Cell Biol Int; 2001; 25(7):679-89. PubMed ID: 11448107 [TBL] [Abstract][Full Text] [Related]
12. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments]. Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094 [TBL] [Abstract][Full Text] [Related]
13. Interleukin 10 blocks matrix metalloproteinase-2 and membrane type 1-matrix metalloproteinase synthesis in primary human prostate tumor lines. Stearns ME; Wang M; Hu Y; Garcia FU; Rhim J Clin Cancer Res; 2003 Mar; 9(3):1191-9. PubMed ID: 12631625 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells. O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134 [TBL] [Abstract][Full Text] [Related]
15. Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Long L; Nip J; Brodt P Cancer Res; 1994 Jul; 54(14):3732-7. PubMed ID: 7518344 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. Qin H; Moellinger JD; Wells A; Windsor LJ; Sun Y; Benveniste EN J Immunol; 1998 Dec; 161(12):6664-73. PubMed ID: 9862695 [TBL] [Abstract][Full Text] [Related]
17. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas. Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064 [TBL] [Abstract][Full Text] [Related]
18. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Dunn SE; Ehrlich M; Sharp NJ; Reiss K; Solomon G; Hawkins R; Baserga R; Barrett JC Cancer Res; 1998 Aug; 58(15):3353-61. PubMed ID: 9699666 [TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626]. Wu MF; Liao GN; Jia P; Xi L; Lu YP; Ma D Ai Zheng; 2004 Nov; 23(11):1263-6. PubMed ID: 15522170 [TBL] [Abstract][Full Text] [Related]
20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]